Biological phenotype and coreceptor usage of human immunodeficiency virus (a short review)

Acta Microbiologica et Immunologica Hungarica

Volumn 47, Issue 2-3, 2000, Pages 131-142

  Fenyö, Eva Maria ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Coreceptor usage; HIV biological phenotype

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

VIRUS RECEPTOR;

CELL LINE; CLASSIFICATION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOGENICITY; PHENOTYPE; PHYSIOLOGY; REVIEW; VIROLOGY; VIRULENCE; VIRUS GENE;

CELL LINE; GENES, VIRAL; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; PHENOTYPE; RECEPTORS, HIV; VIRULENCE;

EID: 0033643249     PISSN: 12178950     EISSN: None     Source Type: Journal    
DOI: 10.1556/AMicr.47.2000.2-3.1     Document Type: Short Survey

References (39)

1. Joag, S.V., Stephens, E.B., Narayan, O.: Lentiviruses. In K.H. Fields (ed.): Fields Virology. Lippincott-Raven, Philadelphia-New York, 1996. pp. 1977-1996.
2. Marlink, R., Kanki, P., Thior, L., Travers, K., Eisen, G., Siby, T. et al.: Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 265, 1587 (1994).
3. Åsjö, B., Morfeldt-Månson, L., Albert, J., Biberfeld, G., Karlsson, A., Lidman, K. et al.: Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet ii, 660 (1986).
4. Fenyö, E.M., Morfeldt-Månson, L., Chiodi, F., Lind, A., von Gegerfelt, A., Albert, J. et al.: Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J Virol 62(11), 4414 (1988).
5. Tersmette, M., De Goede, R.E.Y., Al,B.J., Winkel, L., Gruters, B., Cuypers, H.T. et al.: Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol 62(6), 2026 (1988).
6. Fiore, J.R., Björndal, Å., Aperia-Peipke, K., Di Stefano, M., Angarano, G., Pastore, G. et al.: The biological phenotype of HIV-1 is usually retained during and after sexual transmission. Virology 204, 297 (1994).
7. Tersmette, M., Gruters, B.A., de Wolf, F., de Goede, R.E.Y., Lange, J.M.A., Schellekens, P.T.A. et al.: Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: Studies on sequential isolates. J Virol 63, 2118 (1989).
8. Koot, M., Keet, LP.M., Vos, A.H.V., de Goede, R.E.Y., Roos, M.T.L., Coutinho, R.A. et al.: Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 118, 681 (1993).
9. Karlsson, A., Parsmyr, K., Sandström, E., Fenyö, E.M., Albert, J.: MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection. J Clin Microbiol 32, 364 (1994).
10. Dalgleish, A.G., Beverly, P.C.L., Clapman, P.R., Crawford, D.H., Greaves, M.F., Weiss, R.A.: The CD4 (T4) antigen is an essential component of receptor for AIDS retrovirus. Nature 312, 763 (1984).
11. Klatzman, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T. et al.: T-lymphocyte T4 molecule behaves as the receptor for human retroviral LAV. Nature 312, 767 (1984).
12. Maddon, P.J., Dalgleish, A.G., McDougal, J.S., Clapham, P.R., Weiss, R.A., Axel, R.: The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47, 333 (1986).
13. Clapham, P.R., Blanc, D., Weiss, R.A.: Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by Simian immunodeficiency virus. Virology 181, 703 (1991).
14. Feng, Y., Broder, C.C., Kennedy, P.E., Berger, E.A.: HIV-1 entry cofactor - functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272(5263), 872 (1996).
15. Deng, H.K., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M. et al.: Identification of a major co-receptor for primary isolates of HIV-1. Nature 381(6584), 661 (1996).
16. Deng, H., Unutmaz, D., KewalRamani, V.N., Littman, D.R.: Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388, 296 (1997).
17. Dragic, Y., Litwin, V., Allaway, G.P., Martin, S.R., Huang, Y.X., Nagashima, K.A. et al.: HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-S. Nature 381(6584), 667 (1996).
18. Björndal, Å., Deng, H., Jansson, M., Fiore, J.R., Colognesi, C., Karlsson, A. et al.: Co-receptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 71, 7478 (1997).
19. Scarlatti, G., Tresoldi, E., Bjömdal, Å., Fredriksson, R., Colognesi, C., Deng, H. et al.: In vivo evolution of HIV-1 coreceptor usage and sensitivity to chemokine-mediated suppression. Nature Medicine 3, 1259 (1997).
20. Berger, E.A., Doms, R.W., Fenyö, E.M., Korber, B.T.M., Littman, D.R., Moore, J.P. et al.: A new classification for HIV-1. Nature 391, 240 (1998).
21. Murphy, P.M.: Chemokine receptors: Structure, function and role in microbial pathogenesis. Cytokine & Growth Factor Reviews 7, 47 (1996).
22. Bleul, C.C., Farzan, M., Choe, H., Parolin, C., Clark-Lewis, L., Sodroski, J. et al.: The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829 (1996).
23. Oberlin, E., Amara, A., Bachelerie, F., Bessia, C., Virelizier, J.-L., Arenzana-Seisdedos, F. et al.: The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382, 833 (1996).
24. Cocchi, F., DeVico, A.L., Garzino-Demo, A., Arya, S.K., Gallo, R.C., Lusso, P.: Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HTV-suppressive factors produced by CDB+ T cells. Science 270(5243), 1811 (1995).
25. Moser, B.: Chemokines and HIV: a remarkable synergism. Trends in Microbiology 5, 88 (1997).
26. KewalRamani, V.N., Volsky, B., Kwon, D.S., Xiang, W.-K., Gao, J., Unutmaz, D. et al.: Unpublished data, 1998.
27. Cheng-Mayer, C., Seto, D., Tateno, M., Levy, J.A.: Biological features of HIV-1 that correlate with virulence in the holt. Science 240, 80 (1988).
28. Jansson, M., Popovic, M., Karlsson, A., Cocchi, F., Rossi, P., Albert, J. et al.: Sensitivity to inhibition by (3-chemokines correlates with biological phenotype of primary HIV-1 isolates. Proc Natl Acad Sci USA 93, 15382 (1996).
29. Jansson, M.B.E., Björndal, Å., Holmberg, V., Rossi, P., Fenyö, E.M., Popovic, M. et al.: Coreceptor usage and RANTES Sensitivity of NSI isolates obtained from patients with AIDS. Submitted, 1999.
30. Carr, J.K., Foley, B.T., Leitner, T., Salminen, M., Korber, B., McCutchan, F.: Reference sequences representing the principalgenetic diversity of HIV-1 in the pandemic. In K.E. et al. (eds): Human Retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos. 1998. pp. III-10-III-19.
31. Gao, F., Bailes, E., Robertson, D.L., Chen, Y., Rodenburg, C.M., Michael, S.F. et al.: Origin of HIV-1 in Pan troglodytes troglodytes. Nature 397, 436 (1999).
32. Liitsola, K., Tashkinova, L., Laukkanen, T., Korovim, G., Smolskaja, T., Momot, O. et al.: HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS 12, 1907 (1998).
33. WHO Network for HIV Isolation and Characterisation, HIV type 1 variation in World Health Organisation-sponsored vaccine evaluation sites: Genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. AIDS Res Hum Retroviruses 10, 1327 (1994).
34. Rübsamen-Waigmann, H., von Briesen, H., Holmes, H., Björndal, Å., Korber, B., Esser, R. et al.: Standard conditions of virus isolation reveal biological variability of HIV-1 in different regions of the world. AIDS Research and Human Retroviruses 10, 1401 (1994).
35. Tscherning, C., Alaeus, A., Fredriksson, R., Björndal, Å., Deng, H., Littman, D.R. et al.: Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 241, 181 (1998).
36. Björndal, Å., Sönnerborg, A., Tscherning, C., Albert, J., Fenyö, E.M.: Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS-patients. AIDS Research and Human Retroviruses 15, 647 (1999).
37. Mörner, A., Björndal, Å., Albert, J., KewalRamani, V., Littman, D.R., Inoue, R. et al.: Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCRS but show promiscuity in coreceptor usage. J Virol 73, 2343 (1999).
38. Liu, R., Paxton, W.A., Choe, S., Ceradini, D., Martin, S.R., Horuk, R. et al.: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367 (1996).
39. Satuson, M., Libert, F., Doranz, B.J., Rucker, J., Liesnard, C., Farber, C.-M. et al.: Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722 (1996).